Simpson Bruce W 4

Accession 0001144204-12-039619

CIK 0000887497other

View on SEC.gov Company Profile

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 4:18 PM ET

Size

25.6 KB

Accession

0001144204-12-039619

Insider Transaction Report

Form 4

Period: 2012-07-12

HI TECH PHARMACAL CO INCHITK

Simpson Bruce W

Director

Transactions

Exercise/Conversion
Common Stock
2012-07-12$9.65/sh+6,187$59,705→ 9,281 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−6,188→ 3,093 total
Exercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (6,188 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−1,907→ 5,000 total
Exercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (1,907 underlying)
Exercise/Conversion
Common Stock
2012-07-13$19.59/sh+1,907$37,358→ 1,907 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−3,094→ 0 total
Exercise: $14.99From: 2007-11-09Exp: 2016-11-09→ Common Stock (3,094 underlying)
Sale
Common Stock
2012-07-13$29.33/sh−1,907$55,932→ 0 total
Exercise/Conversion
Common Stock
2012-07-12$5.83/sh+6,188$36,076→ 15,469 total
Exercise/Conversion
Common Stock
2012-07-12$19.59/sh+3,093$60,592→ 18,562 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−3,093→ 6,907 total
Exercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (3,093 underlying)
Exercise/Conversion
Common Stock
2012-07-12$14.99/sh+3,094$46,379→ 3,094 total
Sale
Common Stock
2012-07-12$27.75/sh−18,562$515,096→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−6,187→ 0 total
Exercise: $9.65From: 2008-11-15Exp: 2017-11-15→ CommonStock (6,187 underlying)

Footnotes (5)

[F1]The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.05, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.24 to $29.48, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
[F4]The option became (or becomes) exercisable in four equal annual installments beginning on the first anniversary of the grant date.
[F5]Other than the options to acquire an aggregate of 8,093 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 22,375 shares of Hi-Tech Pharmacal Co., Inc. common stock (for total options to acquire an aggregate of 30,468 shares currently held by the filer) which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.

Documents

1 file

4
form451948_20120716041751-.xmlPrimary

Issuer

HI TECH PHARMACAL CO INC

CIK 0000887497

→

Entity typeother

Related Parties

filerCIK 0001303569

Filing Metadata

Form type: 4
Filed: Jul 15, 8:00 PM ET
Accepted: Jul 16, 4:18 PM ET
Size: 25.6 KB

View on SEC.gov